Evaluating risk of recurrence in patients with meningioma

被引:3
|
作者
Traylor, Jeffrey I. [1 ]
Plitt, Aaron R. [1 ,2 ]
Hicks, William H. [1 ]
Mian, Tabarak M. [1 ]
Mickey, Bruce E. [1 ]
Barnett, Samuel L. [1 ]
机构
[1] Univ Texas Southwestern Med Ctr, Dept Neurol Surg, Dallas, TX USA
[2] Univ Texas Southwestern Med Ctr, Dallas, TX 75390 USA
关键词
meningioma; recurrence; location; extent of resection; brain invasion; adjuvant radiosurgery; oncology; SIMPSON GRADING SYSTEM; CENTRAL-NERVOUS-SYSTEM; INTRACRANIAL MENINGIOMAS; NEUROSURGICAL TREATMENT; BENIGN MENINGIOMAS; SURGERY; CLASSIFICATION; RESECTION; SCALE; RELEVANCE;
D O I
10.3171/2022.6.JNS221162
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Meningioma prognostication and treatment continues to evolve with an increasing understanding of tumor biology. In this study, the authors aimed to test conventional predictors of meningioma recurrence, histopathology variables for which there exists some controversy (brain invasion), as well as a novel molecular-based location paradigm. METHODS This is a retrospective study of a consecutive series of patients with WHO grade I-III meningioma resected at The University of Texas Southwestern Medical Center between 1994 and 2015. Time to meningioma recurrence (i.e., recurrence-free survival [RFS]) was the primary endpoint measured. Kaplan-Meier curves were constructed and compared using log-rank tests. Cox univariate and multivariate analyses were performed to identify predictors of RFS. RESULTS A total of 703 consecutive patients with meningioma underwent resection at The University of Texas Southwestern Medical Center between the years 1994 and 2015. A total of 158 patients were excluded for insufficient follow-up (< 3 months). The median age of the cohort was 55 years (range 16-88 years) and 69.5% (n = 379) were female. The median follow-up was 48 months (range 3-289 months). There was not a significantly increased risk of recurrence in patients with evidence of brain invasion, in patients with otherwise WHO grade I meningioma (Cox univariate HR 0.92, 95% CI 0.44-1.91, p = 0.82, power 4.4%). Adjuvant radiosurgery to subtotally resected WHO grade I meningiomas did not prolong the time to recurrence (n = 52, Cox univariate HR 0.21, 95% CI 0.03-1.61, p = 0.13, power 71.6%). Location (midline skull base, lateral skull base, and paravenous) was significantly associated with RFS (p < 0.01, log-rank test). In patients with high-grade meningiomas (WHO grade II or III), location was predictive of RFS (p = 0.03, log-rank test), with paravenous meningiomas exhibiting the highest rates of recurrence. Location was not significant on multivariate analysis. CONCLUSIONS The data suggest that brain invasion does not increase the risk of recurrence in otherwise WHO grade I meningioma. Adjuvant radiosurgery to subtotally resected WHO grade I meningiomas did not prolong the time to recurrence. Location categorized by distinct molecular signatures did not predict RFS in a multivariate model. Larger studies are needed to confirm these findings.
引用
收藏
页码:621 / 628
页数:8
相关论文
共 50 条
  • [31] GENOMIC MARKERS OF RECURRENCE RISK IN ATYPICAL MENINGIOMA FOLLOWING GROSS TOTAL RESECTION
    Vaubel, Rachael
    Kumar, Rahul
    Weiskittel, Taylor
    Jenkins, Sarah
    Dasari, Surendra
    Uhm, Joon
    Lachance, Daniel Honore
    Brown, Paul
    Van Gompel, Jamie
    Kipp, Benjamin
    Sukov, William
    Giannini, Caterina
    Johnson, Derek
    Raghunathan, Aditya
    NEURO-ONCOLOGY, 2022, 24 : 158 - 158
  • [32] Brain invasion and the risk of seizures in patients with meningioma
    Hess, Katharina
    Spille, Dorothee Caecilia
    Adeli, Alborz
    Sporns, Peter B.
    Brokinkel, Caroline
    Grauer, Oliver
    Mawrin, Christian
    Stummer, Walter
    Paulus, Werner
    Brokinkel, Benjamin
    JOURNAL OF NEUROSURGERY, 2019, 130 (03) : 789 - 796
  • [33] Radiopathologic predictors of recurrence in patients with a gross totally resected atypical meningioma
    Anand, Sharath Kumar
    Sardari, Hamid
    Sadeghsalehi, Alireza
    Bagheri, Seyed Reza
    Eden, Sonia, V
    Lawton, Michael T.
    Alimohammadi, Ehsan
    NEUROLOGICAL RESEARCH, 2022, 44 (05) : 468 - 474
  • [34] A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After Resection
    Chen, William C.
    Vasudevan, Harish N.
    Choudhury, Abrar
    Pekmezci, Melike
    Lucas, Calixto-Hope G.
    Phillips, Joanna
    Magill, Stephen T.
    Susko, Matthew S.
    Braunstein, Steve E.
    Bush, Nancy Ann Oberheim
    Boreta, Lauren
    Nakamura, Jean L.
    Villanueva-Meyer, Javier E.
    Sneed, Penny K.
    Perry, Arie
    McDermott, Michael W.
    Solomon, David A.
    Theodosopoulos, Philip, V
    Raleigh, David R.
    NEUROSURGERY, 2020, 88 (01) : 202 - 210
  • [35] A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence
    Nguyen, Minh P.
    Morshed, Ramin A.
    Youngblood, Mark W.
    Perlow, Haley K.
    Lucas, Calixto-Hope G.
    Patel, Akash J.
    Palmer, Joshua D.
    Horbinski, Craig M.
    Magill, Stephen T.
    Chen, William C.
    Raleigh, David R.
    NEURO-ONCOLOGY, 2024, 27 (02) : 445 - 454
  • [36] FACTORS INFLUENCING MENINGIOMA RECURRENCE RATE
    NAUMANN, M
    MEIXENSBERGER, J
    ACTA NEUROCHIRURGICA, 1990, 107 (3-4) : 108 - 111
  • [37] Simpson grading as predictor of meningioma recurrence
    Quddusi, Ayesha
    Shamim, Muhammad Shahzad
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2018, 68 (05) : 819 - 821
  • [38] Mutation status, epithelial differentiation and location stratify risk for tumor recurrence in chordoid meningioma
    Georgescu, Maria-Magdalena
    Li, Yan
    Olar, Adriana
    Mobley, Bret
    Faust, Phyllis
    Raisanen, Jack
    MODERN PATHOLOGY, 2019, 32
  • [39] The applicability of established clinical and histopathological risk factors for tumor recurrence during long-term postoperative care in meningioma patients
    Luethge, Swenja
    Spille, Dorothee Caecilia
    Steinbicker, Andrea Ulrike
    Schipmann, Stephanie
    Streckert, Eileen Maria Susanne
    Hess, Katharina
    Grauer, Oliver Martin
    Paulus, Werner
    Stummer, Walter
    Brokinkel, Benjamin
    NEUROSURGICAL REVIEW, 2022, 45 (02) : 1635 - 1643
  • [40] Mutation status, epithelial differentiation and location stratify risk for tumor recurrence in chordoid meningioma
    Georgescu, Maria-Magdalena
    Li, Yan
    Olar, Adriana
    Mobley, Bret
    Faust, Phyllis
    Raisanen, Jack
    LABORATORY INVESTIGATION, 2019, 99